Company Filing History:
Years Active: 2003
Title: The Innovative Mind of Andy Uhrberg
Introduction
Andy Uhrberg, an inventor based in Monroe, WA, has made significant contributions to the field of medical device technology. With one patent to his name, he is recognized for his innovative approach to treating vein graft lesions, showcasing a blend of engineering and medical expertise.
Latest Patents
Uhrberg's notable patent, titled "Method and apparatus for treating vein graft lesions," introduces a unique system for ablating material in vein grafts. This invention features an ablation burr rotated by a driveshaft, equipped with channels and blades that effectively direct the ablated material and liquid towards a vessel wall. The incorporation of aspiration technology facilitates the removal of ablated material and liquid from the treatment area. This patent not only addresses the challenges associated with vein graft treatments but also offers improved methods for treating both vein grafts and original native arteries.
Career Highlights
Andy Uhrberg is currently affiliated with Scimed Life Systems, Inc., where he continues to advance medical technology through his research and development efforts. His work focuses on innovative solutions that can enhance patient outcomes and improve surgical procedures. Uhrberg's commitment to innovation is evident in the meticulous design and functionality of his patented system.
Collaborations
Uhrberg has teamed up with prominent colleagues such as Rodney J Bruneau and Robert Lawrence Barry. Their collaborative efforts highlight a shared dedication to pushing the boundaries of medical technology, ensuring advancements that can benefit a wide range of patients requiring vein graft interventions.
Conclusion
Through his inventive spirit and collaboration with talented professionals, Andy Uhrberg has made notable strides in medical device technology. His patent serves as a testament to the potential of innovation in improving healthcare solutions. As the industry evolves, Uhrberg's contributions may continue to pave the way for new methods and technologies in the treatment of vein graft lesions.